Quality control, analysis and secure sharing of Luminex® immunoassay data using the open source LabKey Server platform

[1]  F. J. Wal,et al.  Bead-based immunoassays , 2014 .

[2]  Linda J. Harris,et al.  Quality control, analysis and secure sharing of Luminex® immunoassay data using the open source LabKey Server platform , 2013, BMC Bioinformatics.

[3]  Adam Rauch,et al.  Ancillary study management systems: a review of needs , 2013, BMC Medical Informatics and Decision Making.

[4]  Raphael Gottardo,et al.  Comparability and reproducibility of biomedical data , 2012, Briefings Bioinform..

[5]  J Wakefield,et al.  A Robust Bayesian Random Effects Model for Nonlinear Calibration Problems , 2012, Biometrics.

[6]  F. Marincola,et al.  Cancer classification using the Immunoscore: a worldwide task force , 2012, Journal of Translational Medicine.

[7]  S. Iturria,et al.  HTS Assay Validation , 2012 .

[8]  J. Houp,et al.  1-OR: HLA-Bw4 REACTIVE ANTIBODIES IN PATIENTS WITH Bw4 POSITIVE PHENOTYPES , 2012 .

[9]  P. Nickerson,et al.  29-OR: VALIDATION OF THE LUMINEX PLATFORM TO DETECT HLA ANTIBODIES: EFFECT OF STANDARDIZING OPERATION PROCEDURES ON TEST VARIABILITY BY CTOT CORE LABORATORIES , 2012 .

[10]  S. Iturria,et al.  Assay Operations for SAR Support , 2012 .

[11]  M Roederer,et al.  T cell assays and MIATA: the essential minimum for maximum impact. , 2012, Immunity.

[12]  X. Chen,et al.  HIV-1 gp120 Vaccine Induces Affinity Maturation in both New and Persistent Antibody Clonal Lineages , 2012, Journal of Virology.

[13]  Guido Ferrari,et al.  Immune-correlates analysis of an HIV-1 vaccine efficacy trial. , 2012, The New England journal of medicine.

[14]  J. Trojanowski,et al.  Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease. , 2012, Methods.

[15]  T. Spira,et al.  Development and characterization of a bead-based, multiplex assay for estimation of recent HIV type 1 infection. , 2012, AIDS research and human retroviruses.

[16]  Jonathan Katz,et al.  Installation and Use of LabKey Server for Proteomics , 2011, Current protocols in bioinformatics.

[17]  B. Haynes,et al.  Multiple HIV-1-specific IgG3 responses decline during acute HIV-1: implications for detection of incident HIV infection , 2011, AIDS.

[18]  Sylvia Janetzki,et al.  Harmonization of Immune Biomarker Assays for Clinical Studies , 2011, Science Translational Medicine.

[19]  C. Huber,et al.  A methodological framework to enhance the clinical success of cancer immunotherapy , 2011, Nature Biotechnology.

[20]  D. Watkins,et al.  Pyrosequencing Reveals Restricted Patterns of CD8+ T Cell Escape-Associated Compensatory Mutations in Simian Immunodeficiency Virus , 2011, Journal of Virology.

[21]  Allan C. deCamp,et al.  HIV-DNA Priming Alters T Cell Responses to HIV-Adenovirus Vaccine Even When Responses to DNA Are Undetectable , 2011, The Journal of Immunology.

[22]  W. Blattner,et al.  A Phase IIA Randomized Clinical Trial of a Multiclade HIV-1 DNA Prime Followed by a Multiclade rAd5 HIV-1 Vaccine Boost in Healthy Adults (HVTN204) , 2011, PloS one.

[23]  J. Margolick,et al.  Multisite Comparison of High-Sensitivity Multiplex Cytokine Assays , 2011, Clinical and Vaccine Immunology.

[24]  K. Broman,et al.  RESEARCH ARTICLE Open Access Characterization of killer immunoglobulin-like , 2022 .

[25]  Hongmei Gao,et al.  LabKey Server NAb: A tool for analyzing, visualizing and sharing results from neutralizing antibody assays , 2011, BMC Immunology.

[26]  S. Hammer,et al.  Pre-Existing Adenovirus Immunity Modifies a Complex Mixed Th1 and Th2 Cytokine Response to an Ad5/HIV-1 Vaccine Candidate in Humans , 2011, PloS one.

[27]  Tatsuki Koyama,et al.  Accuracy and reproducibility of a multiplex immunoassay platform: a validation study. , 2011, Journal of immunological methods.

[28]  Adam Rauch,et al.  LabKey Server: An open source platform for scientific data integration, analysis and collaboration , 2011, BMC Bioinformatics.

[29]  L. J. Old,et al.  Minimal information about T cell assays: the process of reaching the community of T cell immunologists in cancer and beyond , 2010, Cancer Immunology, Immunotherapy.

[30]  M. McElrath,et al.  Safety and Immunogenicity of a Replication-Defective Adenovirus Type 5 HIV Vaccine in Ad5-Seronegative Persons: A Randomized Clinical Trial (HVTN 054) , 2010, PloS one.

[31]  Sylvia Janetzki,et al.  Improved Endpoints for Cancer Immunotherapy Trials , 2010, Journal of the National Cancer Institute.

[32]  George G Klee,et al.  Antibody-based protein multiplex platforms: technical and operational challenges. , 2010, Clinical chemistry.

[33]  Pamela Warner,et al.  Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand , 2010, Journal of Family Planning and Reproductive Health Care.

[34]  M. Kalos.  An integrative paradigm to impart quality to correlative science , 2010, Journal of Translational Medicine.

[35]  Jerome H. Kim,et al.  Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. , 2009, The New England journal of medicine.

[36]  Sylvia Janetzki,et al.  "MIATA"-minimal information about T cell assays. , 2009, Immunity.

[37]  V. Seyfert-Margolis,et al.  Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays , 2009, BMC Immunology.

[38]  George G Klee,et al.  Measurement and quality control issues in multiplex protein assays: a case study. , 2009, Clinical chemistry.

[39]  Marcella Sarzotti-Kelsoe,et al.  Evaluation and Recommendations on Good Clinical Laboratory Practice Guidelines for Phase I–III Clinical Trials , 2009, PLoS medicine.

[40]  Ferdousi Chowdhury,et al.  Validation and comparison of two multiplex technologies, Luminex and Mesoscale Discovery, for human cytokine profiling. , 2009, Journal of immunological methods.

[41]  Vicki C. Ashley,et al.  Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia , 2008, Journal of Virology.

[42]  Nicholas Shulman,et al.  Development of an automated analysis system for data from flow cytometric intracellular cytokine staining assays from clinical vaccine trials , 2008, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[43]  G. Kuchel,et al.  ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. , 2008, The journals of gerontology. Series A, Biological sciences and medical sciences.

[44]  Nigel W. Hardy,et al.  Promoting coherent minimum reporting guidelines for biological and biomedical investigations: the MIBBI project , 2008, Nature Biotechnology.

[45]  Stephen R Master,et al.  Validation and Quality Control of Protein Microarray-based Analytical Methods , 2008, Molecular biotechnology.

[46]  C. Gouttefangeas,et al.  Toward the harmonization of immune monitoring in clinical trials: Quo vadis? , 2007, Cancer Immunology, Immunotherapy.

[47]  Stephen R Master,et al.  Diagnostic challenges for multiplexed protein microarrays. , 2006, Drug discovery today.

[48]  W. de Jager,et al.  Solid-phase and bead-based cytokine immunoassay: a comparison. , 2006, Methods.

[49]  J. P. McCoy,et al.  Multiplex bead array assays: performance evaluation and comparison of sensitivity to ELISA. , 2006, Methods.

[50]  Adam Rauch,et al.  Computational Proteomics Analysis System (CPAS): an extensible, open-source analytic system for evaluating and publishing proteomic data and high throughput biological experiments. , 2006, Journal of proteome research.

[51]  P. Gottschalk,et al.  The five-parameter logistic: a characterization and comparison with the four-parameter logistic. , 2005, Analytical biochemistry.

[52]  Jens C. Streibig,et al.  Bioassay analysis using R , 2005 .

[53]  G. Enterprise,et al.  The Global HIV/AIDS Vaccine Enterprise: Scientific Strategic Plan , 2005, PLoS medicine.

[54]  BMC Bioinformatics , 2005 .

[55]  A. Christopoulos,et al.  Fitting Models to Biological Data Using Linear and Nonlinear Regression: A Practical Guide to Curve Fitting , 2004 .

[56]  Kathrin U. Jansen,et al.  Simultaneous Quantitation of Antibodies to Neutralizing Epitopes on Virus-Like Particles for Human Papillomavirus Types 6, 11, 16, and 18 by a Multiplexed Luminex Assay , 2003, Clinical Diagnostic Laboratory Immunology.

[57]  J. W. Pickering,et al.  A multiplexed fluorescent microsphere immunoassay for antibodies to pneumococcal capsular polysaccharides. , 2002, American journal of clinical pathology.

[58]  T. Martins.  Development of Internal Controls for the Luminex Instrument as Part of a Multiplex Seven-Analyte Viral Respiratory Antibody Profile , 2002, Clinical and Vaccine Immunology.

[59]  E R JENNINGS,et al.  The use of control charts in the clinical laboratory. , 1950, American journal of clinical pathology.